Is alt a good short term buy

Altimmune's stock does not appear to be a strong short-term buy. Here's the analysis to support this conclusion:

1. Recent Stock Performance: Altimmune's stock has experienced a decline, with a 1-month interval percentage change of -8.13% and a 1-year percentage change of -44.79%. This indicates a recent trend of the stock price going down.

2. Technical Indicators: The 5-day moving average is $5.91, and the 10-day moving average is $6.16. The fact that the short-term moving average is below the longer-term moving average can suggest a bearish trend.

3. Short Interest: The short interest in Altimmune is substantial, with over 30% of shares shorted. This indicates a negative sentiment among short sellers, which could be a bearish signal.
4. Forecast Price: The forecast price for Altimmune stock in the next ten trading days ranges from $5.86 to $6.44. These prices are below the current closing price of $6.33, suggesting that the forecast sees a potential decline.

5. Analyst Ratings: Despite the negative sentiment, analysts have set an average 12-month price target of $20.25, with a high of $25.00 and a low of $12.00. This suggests that analysts see potential for growth in the long term.

In conclusion, while analysts have set a high price target that could indicate potential for growth, the current technical indicators and short-term forecast suggest that Altimmune's stock may not be a good short-term buy. Investors should consider the potential for short-term price declines and focus on the long-term growth prospects.